Anterior gradient 2 (AGR2), a member of protein disulfide isomerase (PDI) family, is both located in cytoplasm and secreted into extracellular matrix. The orthologs of AGR2 have been linked to limb regeneration in newt and wound healing in zebrafish. In mammals, AGR2 influences multiple cell signaling pathways in tumor formation and in normal cell functions related to new tissue formation like angiogenesis. However, the function of AGR2 in mammalian wound healing remains unknown. This study aimed to investigate AGR2 expression and its function during skin wound healing and the possible application of external AGR2 in cutaneous wound to accelerate the healing process. Our results showed that AGR2 expression was induced in the migrating epidermal tongue and hyperplastic epidermis after skin excision. Topical application of recombinant AGR2 significantly accelerated wound-healing process by increasing the migration of keratinocytes (Kera.) and the recruitment of fibroblasts (Fibro.) near the wounded area. External AGR2 also promoted the migration of Kera. and Fibro. in vitro in a dose-dependent manner. The adhesion domain of AGR2 was required for the formation of focal adhesions in migrating Fibro., leading to the directional migration along AGR2 gradient. These results indicate that recombinant AGR2 accelerates skin wound healing through regulation of Kera. and Fibro. migration, thus demonstrating its potential utility as an alternative strategy of the therapeutics to accelerate the healing of acute or chronic skin wounds.
Introduction
Regenerative medicine is an emerging field of research, which ultimately aims to promote wound healing and tissue repair [1] . Cutaneous wound healing is an orchestrated dynamic process of four distinct phases: hemostasis, inflammation, proliferation, and remodeling [2] . In these phases, several growth factors presumably interact and stimulate different types of cells to proliferate, differentiate, and migrate into the wounded region [2, 3] . Several intensively studied growth factors with locally increased expression during wound healing are epidermal growth factor (EGF), transforming growth factor b (TGF-b), fibroblast growth factor (FGF), and platelet-derived growth factor (PDGF) [1] . Topical applications of these growth factors have shown accelerated wound healing in animal models or in clinical studies [4] [5] [6] [7] . The rate limiting step in wound healing is migration and recruitment of keratinocytes (Kera.), fibroblasts (Fibro.), immune cells, and endothelial cells towards wounded region [3] . During wound repair in normal mammalian systems, the first event of the cell proliferation stage is the migration of Kera. over the injured dermis. During epithelialization, Fibro. migrate into the wounded area to reorganize extracellular matrix, deposit collagen and causing wound contraction [1] [2] [3] 8, 9] . Thus, signal molecules that regulate the migration of Kera., Fibro., and endothelial cells may alter the rate of wound healing.
In lower vertebrates, anterior gradient (AGR) family genes AG1, AGR2, and AGR3 regulate the body appendages regeneration in amphibian, while higher vertebrates like reptiles, birds, and mammals without AG1 gene show reduced levels of body appendages regeneration [10] . Lately, it has been shown that all three genes AG1, AGR2, and AGR3 are associated with regulation of limb and tail regeneration in Xenopus laevis tadpoles [11] and limb regeneration in salamander [12] . A recent study established that AGR2 activating epidermal growth factor receptor (EGFR) signaling is essential for pancreatic tissue regeneration in higher vertebrates [13] . In human, AGR2 promotes the angiogenesis and the invasion of vascular endothelial cells and Fibro. in tumor microenvironment by enhancing FGF and VEGF signaling pathways [14] .
Anterior gradient 2 has been proposed as a potential biomarker to detect circulating tumor cells in the peripheral blood of patients with metastatic cancers [15] . AGR2 also promotes tumor cell migration in multiple cancers like breast cancer, pancreatic cancer, glioblastoma, papillary thyroid carcinoma, and ovarian cancer [16] [17] [18] [19] [20] . AGR2 promotes tumor growth by inducing expression of amphiregulin, a growth promoting EGFR ligand by activation of hippo signaling pathway co-activator yes-associated protein 1 (YAP1) [21] . Knockdown and overexpression of AGR2 confirmed its importance in cell migration, but the exact molecular mechanism of AGR2 function remains poorly understood [17] [18] [19] [20] 22] . Cell migration cycle involves cell polarization, adhesion, and migration. Assembly and disassembly of focal adhesions are controlled by focal adhesion kinase (FAK), extracellular signal-regulated kinase 1/2 (ERK 1/2), protein kinase B (AKT), and c-Jun N-terminal kinase (JNK) signaling pathways as well as microtubule dynamics [23] .
Based on these earlier studies, we hypothesized that secreted AGR2 may also play a critical role in woundhealing process in mammals by promoting the migration of various cell types. In this study, we measured the expression of AGR2 during wound healing and investigated the effect of topically applied recombinant AGR2 on the wounds in a mouse full-thickness skin excision wound model. Here, we report that AGR2 is induced in epidermis of wound and promotes the elongation of epidermal tongue leading to the promotion of cutaneous wound healing. Externally applied AGR2 also promotes directional migration of Fibro. by regulating the formation of focal adhesions. These AGR2 functions in wound healing involve FAK and JNK signaling pathways and require AGR2 adhesion domain (amino acids [21] [22] [23] [24] [25] [26] [27] [28] [29] [30] [31] [32] [33] [34] [35] [36] [37] [38] [39] [40] . Our finding indicates that external AGR2 may represent an alternative strategy for the development of therapeutics for wounds with large exposure area or difficult-to-heal chronic wounds.
Results

AGR2 is expressed in epidermis during cutaneous wound healing, but not in unwounded skin
To investigate the role of AGR2 in skin wound healing, we analyzed AGR2 expression in skin tissues of different growth phase mice by western analysis. We were unable to detect AGR2 expression in skin tissues of newborn or adult mice, while the skin of 14-day embryos clearly showed positive AGR2 expression (Fig. 1A) . Tissue samples of the excision wounds revealed that the expression of AGR2 was increased significantly from day 2 to day 9 postwounding and the expression of keratinocyte proliferation marker, Keratin 14 (K14), was also increased (Fig. 1B) . AGR2 immunostaining in the wound section was weak in the epidermis at day 1 postwounding, but became obviously intense in the migrating epidermal tip and in the hyperplastic epidermis until day 9, when AGR2 expression started to reduce from spinous to granular cells during keratinocyte differentiation (Fig. 1C) . These observations of AGR2 expression in the epidermis during wound healing imply that AGR2 may be involved in the wound healing.
External AGR2 promotes wound healing in vivo via increasing migration of keratinocytes and fibroblasts
To assess the effect of AGR2 in skin wound healing, we generated recombinant AGR2 protein (rAGR2), whose signal peptide (amino acids 1-20) was truncated to mimic the mature secreted protein. Various concentration of rAGR2 was topically applied in mouse fullthickness skin excision wound-healing assays. The wound sizes were measured daily until complete epithelialization. Compared with phosphate buffer saline (PBS)-treated control wounds, the rAGR2-treated wounds recovered faster in the 100 and 250 lgÁmL À1 AGR2 group, but no significant differences were observed between 25 lgÁmL À1 rAGR2 treatment group and PBS control group ( Fig. 2A,B) . Compared with PBS control group, the major differences in wound sizes reduction with high concentration of rAGR2 treatment were observed from day 3 to day 9 postwounding.
To understand the effect of topically applied rAGR2 at tissue level, we compared the differences in the histological structures between PBS-and rAGR2-treated wounds during the healing process. Tissue sections revealed that the migrating epidermal tongues were significantly elongated in rAGR2-treated wounds at day 3 postwounding (Fig. 2C,D) . Next, we compared the number of aSMA-positive myoFibro. in granular tissue to examine fibroplasia level during AGR2 treatment. In rAGR2-treated wounds, the number of myoFibro. was much higher in the wound bed at day 6 postwounding (Fig. 2E,F) . These results suggest that AGR2 promotes the migration of Kera. in the epidermal tongue and the migration of Fibro. toward wounded area with granulation tissue formation.
AGR2 induces the invasion and migration of primary cells ex vivo and in vitro
The histology analysis of the wound edge from rAGR2-treated wounds revealed that AGR2 accelerated the migration of epithelial cells to form elongated migrating tongue. In order to closely examine the AGR2-promoting keratinocyte migration, ex vivo cultures of skin explants with or without AGR2 treatment were compared over a period of 4 days (Fig. 3A) . The outgrowing cells from explants with AGR2 treatment migrated four-fold farther than control treatment. When outgrowth cells from the explants were stained by K14, a marker of Kera., and fibroblast special protein (FSP), a marker of Fibro., we found that only few Kera. were among the cells outgrown from the explants and the most outgrowth cells were Fibro. (Fig. 3A) . These outgrowing cells were collected and analyzed for their ability of invasion and migration by agarose spot invasion assays. Results showed that these ex vivo derived cells migrated under AGR2 containing agarose spots in a dose-dependent manner (Fig. 3B ). Since we knew the outgrowing cells from explants were mostly a mixture of Kera. and Fibro., skin primary Kera. and Fibro. were extracted from newborn pups, and they were used in agarose spot assay to test their response to AGR2 (Fig. 3C) . Both Kera. and Fibro. could migrate under AGR2 containing agarose spot. Similar to ex vivo culture, Fibro. migrated faster than Kera. under AGR2 containing agarose spot. Angiogenesis is necessary to sustain the newly formed granulation tissue, which relied on migration and mitogenic stimulation of endothelial cells [2] . We used human umbilical vein endothelial cells (HUVEC), a common cell line used to study angiogenesis, to evaluate AGR2 function in angiogenesis during skin wound healing. The result showed that AGR2 could promote HUVECs migrating under agarose, but the distance of migration was less compared with Kera. and Fibro. (Fig. 3C) . Additionally, we blocked cell proliferation by mitomycin C in agarose spot assay and there was no obvious difference in migration of Kera. and Fibro. (Fig. 3D ). Boyden chamber migration assays and scratch wound-healing assays also confirmed that AGR2 promoted migration of Kera. and Fibro. (Fig. 3E,F) . These results indicate that AGR2 increases the migration of Kera. and
Fibro., and Fibro. are more responsive to AGR2 treatment than Kera.
Adhesion domain of AGR2 is critical to promote activity of fibroblasts directional migration
Anterior gradient 2 protein has three major functional domains including domains for cell adhesion (amino acids 21-40) [24] , dimerization (amino acids 60-64) [25] , and protein disulfide isomerase (PDI) activity (amino acids 81-84) [26] . To determine AGR2 Fig. 3 . Effects of AGR2 on migration of primary Kera. and Fibro. (A) 2 mm skin punch biopsies of 4-day-old pups were explanted in 0.1% serum media with 5 lgÁmL À1 AGR2 or BSA for 4 days. The outgrowing cells from explants were stained by FSP and K14, presenting in left panel. Red dotted lines demarcate migration edge of Kera. Scale bar, 1 mm. Graphic data showed the distance of outgrowth with or without AGR2 treatment (n = 6). *P < 0.05. (B) Agarose spot invasion assay of the outgrowth cells from explants. Cells were seeded around 0.36% agarose spot containing indicated concentration of AGR2 and incubated for 18 h. BSA served as negative control. Agarose spot edge is indicated by black dotted line. White solid line indicates the edge of cells migration. Scale bar, 100 lm. Graphic data showed the distances of migration which were normalized to BSA treatment (n = 4). (C) Agarose spot invasion assay of primary Kera., primary Fibro., and HUVECs. Cells were seeded around 0.36% agarose spots containing 300 lgÁmL À1 AGR2. Scale bar, 100 lm. (D) Agarose spot invasion assay of 10 lgÁmL À1 mitomycin C-treated Kera. and Fibro. Graphic data showed the distances of migration were normalized to BSA treatment (n = 4). (E) Boyden chamber assay of Kera. and Fibro. with 500 ngÁmL À1 AGR2 or BSA for 18 h. Scale bar, 100 lm. Graphic data showed migrated cell numbers (n = 3). *P < 0.05 (F) Scratch wound-healing assay of Kera. and Fibro. with 100 or 500 ngÁmL À1 AGR2
or 500 ngÁmL À1 BSA for indicate time. Original Scratch edge is demarcated by white dotted line. Scale bar, 100 lm. Graphic data showed the distance of migration (n = 4). **P < 0.01. NS, no significant difference.
functional domains necessary for promoting cell migration, we generated several AGR2 mutants, AGR2 lacking adhesion domain (ADH), AGR2 mutated dimerization domain (DIM), and PDIs, impairing the three major functional domains, respectively (Fig. 4A,B) . When tested in agarose spot invasion assay using agarose spot containing AGR2 mutant in which adhesion domain mutant (ADH) is eliminated, the distance of ADH promoted cell migration was only one-third of wild-type AGR2. Using the same assay with agarose spot containing DIM or PDIs mutant, no significant effects were observed on the migration promoting function compared with wildtype AGR2 (Fig. 4C) . We confirmed these results with scratch wound-healing assay. Our results showed that the adhesion domain mutant impaired the migration promoting effect of AGR2. However, the dimerization domain mutant and the PDI domain mutant had little influence on promoting cell migration (Fig. 4D) . We also used agarose spot to assess the directional migration of Fibro. Beginning from the spot edge, Fibro. showed chemotaxis toward the center of AGR2 spot (Fig. 5A ). This phenomenon may be related to AGR2 protein diffusion from the agarose spot in liquid medium, resulting in a higher concentration of AGR2 at the center with decreasing concentration toward the spot edge. Quantitative analyses showed that both the average migration speed and the directional persistence of Fibro. toward center of AGR2 spot increased significantly compared with bovine serum albumin (BSA; Fig. 5B ,C,D). DIM and PDIs mutants had similar functions as wild-type AGR2 in migration speed and directional migration, but ADH mutant slightly reduced migration speed of Fibro. while significantly reduced the directional persistence of migrating cells toward the center of agarose spot containing ADH mutant compared with wild-type AGR2 (Fig. 5B,C,D) .
To verify whether the migration activity of Fibro. under AGR2 treatment is related to the classical cell migration process, we examined the formation of filamentous network and focal adhesions in the Fibro. around the edge of agarose spots containing AGR2 or BSA. Fibro. were elongated morphologically and generated pseudopodium with strong focal adhesions to migrate across the edge of AGR2 agarose spot (Fig. 6A) . We compared formation of stress fibers and focal adhesions in the Fibro. migrated under agarose containing AGR2 and AGR2 mutants, respectively. Fibro. were polarized toward center of agarose spot containing AGR2 and showed well-aligned stress fibers formatted by stable focal adhesions at the leading edge of cell migration. However, Fibro. at migration edge under agarose spot containing ADH mutant showed vertical stress fibers and few adhesions formation (Fig. 6B ). These observations indicate that AGR2 adhesion domain is required to promote directional migration of Fibro.
AGR2 modifies directional migration of fibroblasts through FAK and JNK pathway
To understand the mechanism of AGR2 function in promoting cell migration, we investigated signaling pathways required for AGR2 function with specific inhibitors against key factors in major signaling pathways to assess the inhibition effect on AGR2 function. In fibroblast agarose spot migration assay, AGR2 function is tested by four inhibitors: PF-562271, a FAK inhibitor; MK2206, an AKT inhibitor; SP00625, a JNK inhibitor; and U0126, a mitogen-activated protein kinase (MEK) inhibitor. FAK inhibitor (Fig. 7A ) and JNK inhibitor (Fig. 7B ) reduced cell migration into the spot significantly, while MEK and AKT inhibitors had no effect on AGR2 function, indicating FAK and JNK are important for this AGR2 function. In AGR2 promoted cell directional migration, JNK inhibitor SP00625 significantly reduced cell velocity and directional persistence. MEK inhibitor had no effect (Fig. 7C,D) . We also investigated the effect of extracellular AGR2 on the expression and phosphorylation of FAK, JNK, ERK, and AKT by western analysis in Fibro. treated with AGR2 for 0, 5, 15, and 30 min. Although no total protein level change was observed in none of these factors, the p-FAK are transiently upregulated between 5 min and 15 min after addition of AGR2 and the p-FAK level returned to normal after 30 min. The transient increase in p-JNK was observed in 15 min after AGR2 stimulation and returned to normal after 30 min. No change in p-ERK and p-AKT levels was observed (Fig. 7F ). All these results indicate that AGR2 function in fibroblast migration involves FAK and JNK phosphorylation.
Discussion
The AGR2 homologs in lower vertebrates play a critical role in wound healing and new tissue regeneration. However, these functions have not been demonstrated in mammalians. In this study, we demonstrated for the first time that the expression of AGR2 is induced in migrating epidermal tongue and hyperplastic epidermis during the wound-healing process of a skin excision mouse model. We also showed that topical application of AGR2 can accelerate wound healing by promoting the migration of Kera. for the extension of epidermal tongue and the migration of Fibro. toward wounded area supporting granulation tissue formation. We revealed that the adhesion domain of AGR2 is required for the directional migration of Fibro. And the AGR2 function involves FAK and JNK pathways to promote Fibro. migration.
Anterior gradient 2 expression was not detectable in unwounded skin, but it was induced at a high level during wound-healing process which is associated with the increased expression of K14. This is consistent with our immunostaining of tissue section of the wound area showing epidermis stained strongly by AGR2 antibody during wound healing. These results showed that Kera. in proliferating phase strongly express AGR2. In cancer cells, AGR2 expression is an area of well-studied, but the full scale of its functions, especially the functions of secreted AGR2, is still not clear [20, [27] [28] [29] . Recent publication revealed that secreted AGR2 promotes endothelial cells and Fibro. migration to form tumor microenvironment [14] . This lead us to hypothesize that the possible role of AGR2 in wound-healing process is to promote the migration of various cell types for the wound-healing process. We observed that AGR2 expression is located in the migration tongue than hyperplastic epidermis, suggesting AGR2 may play an important role in Kera. migration and invasion.
In this study, we examined topical application of AGR2 in a mouse model of full-thickness skin excision wound with three different concentration levels (25 100 and 250 lgÁmL AGR2 concentration required for effective treatment is higher than the topical application of EGF (10 lgÁmL À1 ) to accelerate epidermal repair in partial thickness wounds [4] , but similar to the concentration for topical application of FGF (100-1000 lgÁmL À1 ) for the treatment of chronic pressure sores [7] . Our results of topical AGR2 application showed that aSMApositive cells were increased early at day 6 with AGR2 treatment compared with control. However, near the end of healing at day 9, the number of aSMA-positive cells in the wound bed was not significantly different from that of the control group (Fig. 2E,F) . Therefore, AGR2 treatment seems to promote early fibroblast activation and increase myofibroblast number without abnormal homeostasis, consistent with our observation postwound healing. Wound healing is highly modified by inflammatory mediators, such as cytokines and growth factors, which are released by inflammatory cells, Kera. and Fibro. in the wound region. We observed high expression of AGR2 in epidermis and less expression in granular tissue during wound healing. Additionally, when we applied AGR2 to wounded area externally, we observed that the lengths of migrating epidermal tongue and the number of myoFibro. in the wound bed were both markedly increased. These results indicate that secreted or external AGR2 may exert autocrine effect on Kera. and paracrine effect on the Fibro. to facilitate cell migration which is correlated with recent work published by Tsuji et al. [30] . It is also important to note that externally applied AGR2 accelerated early activation of Fibro. at the wounded region as indicated by aSMA staining. The activation and migration of fibroblast is a critical step in wound healing that requires collagen deposit and fibrillar extracellular matrix structural support from activated Fibro.
It is known that TGF-b stimulates Fibro. chemotaxis in different stages of wound healing. However, although TGF-b1 promotes partial thickness wound healing, it delays the healing of full-thickness skin wound because of its inhibitory function on keratinocyte migration [31] . In this study, we proposed that AGR2 promotes the migration on both Fibro. and Kera. to accelerate full-thickness skin wound healing, which is supported by immunostaining and topical application results, as well as in vitro analysis. Tumor secreted AGR2 has cell-autocrine/paracrine effect which plays a pivotal role in tumor microenvironment [14] . Cancer-secreted AGR2 has been reported to promote the invasion and migration of Fibro., program cell death of stromal cells, and disrupt the polarity of epithelial cells [14, 30, 32, 33] . Remarkably, several functional domains of AGR2 like PDI activity domain, dimerization site, and adhesion domain may be involved in the process of cell migration [24, 26, 34, 35] . In our agarose spot invasion assay, we discovered that extracellular AGR2 attracts the migration of Fibro. through adhesion domain, but not through PDI activity domain or dimerization site. The deletion of adhesion domain decreased directional persistence of fibroblast, which is consistent with the function of this domain in regulating the focal adhesions.
In cell migration, the formation of focal adhesions involves the coordinated action of various classes of molecules, in which FAK was reported to play a key role in assembly and disassembly of the focal adhesions [36] . AGR2 activated FAK signal through increasing the phosphorylation level of FAK and PF-562271, FAK inhibitor, blocks the signal transduction of FAK, leading to the decrease of AGR2-induced cell migration. These results suggest that AGR2 may modify the location of focal adhesion through FAK signaling pathway. Another AGR2-activated cell signal molecule in this study is phosphorylated JNK. Previous studies showed that EGF regulates fibrous tissue remodeling through MEK/ ERK and JNK-mediated signals by affecting the proliferation, migration, and myoFibro. differentiation [37] . Our present study demonstrates that AGR2 function is suppressed by JNK inhibitor SP00625, resulting in decreased migration velocity and directional persistence of Fibro., while MAPK inhibitor U0126 has no influence on AGR2 function. Overall, our results suggest that the full effect of AGR2-promoted Fibro. migration requires FAK pathway and JNK pathway.
Materials and methods
Mouse model and cutaneous wound-healing assay
Animal care and experimental procedures were approved by the Animal Care and Use Committee of Shanghai Jiao Tong University -School of Pharmacy. Eight-week-old BALB/c male mice (Slac Animal Laboratory, Shanghai, China) were used in this study. Mice were anesthetized by intraperitoneal injection of sodium pentobarbital (50 mgÁkg
À1
). The dorsal surfaces of mice were shaved and cleaned with 70% ethanol. Two full-thickness wounds were created on the back of each mouse by an 8-mm-diameter biopsy punch as previously described [38, 39] with minor modification. The puncture wounds were not covered with dressing; 25, 100, or 250 lgÁmL À1 recombinant AGR2 protein and 25 lL PBS were mixed in cream (0.2% methylparaben and 9% laureth/ isoparaffin/polyacrylamide as previously described [40] ) were applied after injury and everyday thereafter. 
Histological examination
For histological analysis, the wounds and surrounding tissues were collected and fixed with 4% formaldehyde. The tissues were embedded in paraffin and 10-lm sections from the central part of the wound were stained with hematoxylin and eosin (H-E). Immunohistochemistry (IHC) assays were performed as previously described [41] and with anti-AGR2 antibody (1 : 100; Abgent, San Diego, CA, USA) and antia-SMA antibody (1 : 200; Abcam, Cambridge, UK). The lengths of the migrating epithelial tongue were the length of epidermis from wound edge to epithelial migrating leading edge, measured from the images of both sides of wounds at day 3 postwounding (n = 6). For the quantification of aSMA-positive area percentage, wound beds next to wound edge were photographed and aSMA-positive areas showing brown were measured by IMAGE PRO PLUS software.
Isolation of primary keratinocytes and fibroblasts
The primary Kera. were isolated from the skin of newborn mice as described previously with minor modifications [42] . Briefly, the skin of mice was dissected, treated with cold, sterile 0.25% trypsin solution, and incubated at 4°C for 24 h. The epidermis was separated from the dermis with sterile forceps, minced, and suspended in 10 mL of growth medium. The suspension was agitated to create a single-cell suspension and then passed through a sterile 70 lm nylon filter cell strainer to remove any sheets of dead cells. The entire 10 mL of keratinocyte suspension obtained from each skin was plated onto a 10-cm tissue culture dish coated with Poly-L-lysine and cultured in complete media [Dulbecco's modified Eagle's medium (DMEM) supplemented with 10% FBS and 1% penicillin/streptomycin] at 37°C, 5% CO 2 . For fibroblast isolation, dermal pieces were finely minced and immersed in 0.25% trypsin solution and incubated at 4°C for 18 h. 10 mL of growth medium was added to the dermis suspension, and the mixture was briefly stirred and passed through a sterile 70 lm nylon filter cell strainer. The filtered dermis suspension was plated into 10-cm tissue culture dish coated with poly-L-lysine and cultured in complete media at 37°C, 5% CO 2 .
All experiments were performed using cells from the third to the fifth passage.
Skin explants culture
Skin explants were prepared as previously described [43] . Two-millimeter diameter punch biopsy from 4-day-old pups was placed and gently pressed onto the bottom of a 24-well plate. Two-hundred microliters of 10% FBS DMEM was added to the explants and the culture dish gently placed at 37°C, 5% CO 2 incubator. After 12 h, explants were incubated in 1.5 mL 0.1% FBS, 1% penicillin/streptomycin DMEM containing either 5 lgÁmL À1 BSA (Sigma-Aldrich, St. Louis, MO, USA) or AGR2. Outgrowing cells from explants were photographed every day. For immunostaining, outgrowing cells from explants were fixed with 4% paraformaldehyde for 15 min followed by 100% methanol for 4 min. Cells were immunostained using anti-K14 antibody (1 : 50; Abgent), anti-FSP antibody (1 : 100; Abcam), and IHC Detection Kit (Solarbio, Beijing, China).
Plates were photographed and the total area of outgrowth was measured using IMAGE PRO PLUS software.
Agarose-protein spot cell culture assay
We adapted the protocol as previously described [44] . Briefly, 0.5% agarose was boiled and cooled to 40°C and then mixed in a 3 : 7 solution with 1 mgÁmL À1 of recombinant AGR2 protein. From this solution of 0.35% agarose, 10 lL (3 lg of AGR2) was dropped on to a 25 mm glass petri dish. As a control, BSA (Sigma-Aldrich) was spotted on the same dish. Petri dishes were incubated at 4°C for 10 min; 1.5 9 10 5 cells per well primary Kera., Fibro., and HUVE cells were then plated in complete media and left at 37°C for 4 h. No cells were observed to adhere beneath any of the agarose spots at this stage. The medium was then changed to migration medium (DMEM, 0.1% FBS, and 1% penicillin/ streptomycin) and dishes were left at 37°C in 5% CO 2 . Cells were analyzed and photographed at 18-h treatment. To investigate the role of FAK, AKT, JNK or MEK in cell migration, Fibro. were pretreated with 5 nM or 500 nM PF-562271, 100 nM MK2206, 1 lM SP00625, or 10 lM U0126 (all are from Selleck Chemicals, Houston, TX, USA), respectively, for 4 h before seeding around agarose spot. To analyze the trajectory of Fibro. under agarose spot, Fibro. were stained with lipophilic dyes DiO (Blue) or DiD (red) (Molecular Probes, Inc., Eugene, OR, USA) and mixed with unstained cell by 1 : 1 : 4, respectively. The mixture of Fibro. was plated around agarose for 2 h to settle down, and 0-h image was taken as soon as migration medium was changed and photographed every 3 h. The trajectory of Fibro. was measured as previously described [45] .
Generation of recombinant AGR2 and AGR2 mutants
In-house recombinant human AGR2 (His-AGR2) was purified by Ni affinity chromatography from E. coli (Escherichia coli) expressing N-terminal His-tagged recombinant AGR2 whose 1-20 a.a. signal peptide was deleted. AGR2 mutants were generated from pHis-AGR2 plasmid by Mutagenesis Kit (Toyobo, Osaka, Japan) and purified as recombinant AGR2. 
